Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2025-2031

The global Targeted RNA Sequencing market size is predicted to grow from US$ 2635 million in 2025 to US$ 9278 million in 2031; it is expected to grow at a CAGR of 23.3% from 2025 to 2031.

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

In the report, we only collect information about the companies who can provide targeted RNA sequencing service.

Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.

North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.

LPI (LP Information)' newest research report, the “Targeted RNA Sequencing Industry Forecast” looks at past sales and reviews total world Targeted RNA Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted RNA Sequencing sales for 2025 through 2031. With Targeted RNA Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted RNA Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Targeted RNA Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted RNA Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted RNA Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted RNA Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted RNA Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted RNA Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing

Segmentation by Application:
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ

Please note: The report will take approximately 2 business days to prepare and deliver.